Lifecore Biomedical (LFCR) Debt to Equity (2011 - 2026)
Lifecore Biomedical (LFCR) debt to equity from May 29, 2011 to Mar 31, 2026. The current Lifecore Biomedical (LFCR) debt to equity is -526.37%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Lifecore Biomedical (LFCR)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | -1008.38% | -110.09% |
| 2025 | 9990.30% | N/A |
| 2025 | 9990.30% | +1013.20% |
| 2024 | 897.44% | -19.12% |
| 2024 | 1109.63% | -155.32% |
| 2023 | -2005.67% | N/A |
| 2023 | 0.00% | -100.00% |
| 2023 | 282.41% | +103.04% |
| 2022 | 139.09% | +9.90% |
| 2022 | 126.57% | +13.21% |
| 2022 | 111.80% | +3.28% |
| 2022 | 108.25% | +93.87% |
| 2022 | 55.84% | N/A |
| 2022 | 0.00% | -100.00% |
| 2021 | 79.91% | N/A |
| 2021 | 0.00% | -100.00% |
| 2021 | 64.12% | N/A |
| 2021 | 0.00% | -100.00% |
| 2021 | 81.65% | +0.41% |
| 2021 | 81.32% | +13.36% |
| 2021 | 71.74% | +60.11% |
| 2020 | 44.80% | -6.71% |
| 2020 | 48.02% | -2.25% |
| 2020 | 49.13% | N/A |
| 2020 | 0.00% | -100.00% |
| 2019 | 35.90% | N/A |
| 2019 | 0.00% | -100.00% |
| 2018 | 16.75% | -19.66% |
| 2017 | 20.85% | N/A |
| 2017 | 20.85% | -19.63% |
| 2016 | 25.94% | +1.50% |
| 2016 | 25.55% | +31.27% |
| 2015 | 19.47% | +15.01% |
| 2014 | 16.93% | -24.97% |
| 2013 | 22.56% | -28.62% |
| 2012 | 31.60% | +116.83% |
| 2011 | 14.57% | N/A |
Comparison Lifecore Biomedical (LFCR) debt to equity with competitors
Lifecore Biomedical (LFCR) debt to equity is -526.37%.